Frontiers in Oncology (Apr 2022)
Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
- Xiaoxiang Rong,
- Jinyu Lv,
- Yantan Liu,
- Zhaojun Wang,
- Dongqiang Zeng,
- Yuedan Li,
- Shaowei Li,
- Jianhua Wu,
- Zheyu Shen,
- Min Shi,
- Wangjun Liao,
- Zhenzhen Wu,
- Chunlin Wang
Affiliations
- Xiaoxiang Rong
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Jinyu Lv
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Yantan Liu
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Zhaojun Wang
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Dongqiang Zeng
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Yuedan Li
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Shaowei Li
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Jianhua Wu
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Zheyu Shen
- School of Biomedical Engineering, Southern Medical University, Guangzhou, China
- Min Shi
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Wangjun Liao
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Zhenzhen Wu
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- Chunlin Wang
- Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China
- DOI
- https://doi.org/10.3389/fonc.2022.895938
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- gastric cancer
- PD-1
- immune checkpoint blockade
- tumor microenvironment
- biomarker
- cancer-associated fibroblasts
